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Adhesions after abdomino-pelvic surgery are a cause of morbidity and reoperations. 
The use of human amniotic membrane (HAM) for adhesion prevention has given contro-
versial results. The mode of administration of the amniotic membrane has not been well 
studied. This study assessed the efficacy of two modes of application of cryopreserved 
HAM, patch or fragmented in Lactated Ringer (LR) solution, for the prevention of pelvic 
adhesion formation postabdomino-pelvic surgery in a mice model. After a midline lap-
arotomy incision, a small cautery lesion was done on each side of the abdominal wall 
peritoneum in mice. In Group A (control; n =  42), the abdomen was closed directly, 
Group B (n = 42) received 2.5 ml of LR prior to closure. In Groups C (n = 42) and D 
(n = 42), a 2 cm × 2 cm patch of HAM and another one fragmented and dispersed in 
2.5 ml of LR were applied prior to closure, respectively. Two weeks later, a laparotomy 
was performed, and gross and pathological evaluation of adhesions, fibrosis, angiogen-
esis, and inflammation were conducted. Group D exhibited a significantly lower rate of 
gross adhesion formation. Fibrosis was significantly lowest in Group C as compared 
to the control. Group B had the lowest vascular formation in the adhesions. The use 
of HAM fragmented in LR solution is associated with a significantly lower incidence of 
postoperative adhesions in mice when compared to LR alone, HAM patch, or control. 
The mechanism of action of this reduction needs to be elucidated by future studies.
Keywords: human amniotic membrane, abdomino-pelvic surgery, adhesion, mouse model, lactated ringer
inTrODUcTiOn
Adhesions are considered a major postoperative complication of abdominal and pelvic surgeries. 
They lead to significant clinical morbidities ranging from infertility, small bowel obstruction, pelvic 
pain, and future surgical complications (1, 2). Several agents have been proposed to decrease their 
occurrence, including antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, 
March 2016 | Volume 3 | Article 102
Nassif et al. HAM and Adhesion Prevention
Frontiers in Medicine | www.frontiersin.org
fibrinolytics, reactive oxygen species (ROS) scavengers, calcium 
channel blockers, and GnRH analogs (3). Most of these agents 
have only been tested in animals, with some showing positive 
results; however, data from human trials are very limited. Several 
synthetic agents, which create a barrier between injured tissues 
throughout the peritoneal healing timeframe, have been proposed 
and used as adhesion prophylaxis agents. They can be site-specific 
(mechanical) or broad-coverage (gel or fluid) agents (2–4). 
Although some of these agents effectively reduce postsurgical 
adhesions, their use has many drawbacks, including difficulty in 
applying such agents in open or laparoscopic surgeries, decrease 
in their efficacy in the presence of bleeding, need for special and 
complex equipment for their application, and the high cost of 
most of those agents (1–3). Natural membranes such as omentum 
or peritoneal membranes have also been used but owing to their 
immunogenicity, they cannot be an ideal heterograft (5).
Human amniotic membrane (HAM) is a collagen avascular 
matrix with a basement membrane and a monolayer of epithelial 
cells and harbors macrophages and myofibroblasts. Many charac-
teristics render it ideal to be used in adhesion prophylaxis since it 
is almost always available, easy to harvest, prepare, and sterilize, 
and it can be stored easily for several months at −80°C (6). HAM 
acts in two ways: suppression of adhesion formation by suppress-
ing stromal inflammation, angiogenesis, fibrosis, and scarring (7) 
and enhancing wound healing by promoting epithelialization of 
the injured sites. HAM expresses HLA-A, HLA-B, HLA-C, HLA-G 
antigens, but not the HLA-DR antigen or B2-microglobulin 
(5, 6, 8, 9), and has anti-inflammatory and anti-microbial 
activities (5, 7). In the past few years, HAM has been used as 
biological membranes in the treatment of burns, lesions, and ulcers 
(6, 9); surgical repair of artificial vagina; and omphalocele repair 
(6, 10). HAM is most widely used in ophthalmic surgeries and in 
the treatment of various diseases of the external eye (11).
Various studies have assessed the utilization of HAM in adhe-
sion prophylaxis alone or in combination with other pharmaceu-
tical agents (4, 5, 12). Most of these studies have utilized the HAM 
as a patch (13, 14). HAM has also been tested with agents such 
as heparin, Seprafilm (15), and several other substances to look 
for an increased anti-adhesion action (16–18). In addition, it was 
compared to hyaluronate/carboxymethylcellulose membrane 
(19). However, to the best of our knowledge, HAM has not been 
compared to the Lactated Ringer (LR) solution and has not been 
studied in the fragmented form in LR solution. The aim of our 
study is to assess the efficacy of the mode of application of the 
HAM, patch or fragmented in LR solution, in preventing post-
operative adhesion formation in a mouse model compared with 
LR alone.
MaTerials anD MeThODs
ethics statement
The American University of Beirut’s Institutional Review Board 
and the Institutional Animal Care and Use Committee approved 
the study. All the research was conducted in compliance with The 
Code of Ethics of the World Medical Association (Declaration of 
Helsinki) for experiments involving humans, and EU Directive 
(2010/63/EU) for animal experiments. All prospective patients 
were informed about the study in detail, and an informed consent 
was signed prior to the procedure by those willing to donate the 
amniotic membrane.
sample size calculation
With a hypothesized effect size of 50% and under the assumptions 
of a type-I error (two sided) of 5% and a power of 90%, 42 mice 
per arm for the control and different therapeutic groups were 
estimated to be needed. Using a computer generated list, mice 
were randomized into four groups (A: control, B: LR, C: HAM 
patch, and D: fragmented HAM in LR) of 42 mice each.
Patient recruitment
Human amniotic membranes were collected from five consecu-
tive patients undergoing an elective cesarean delivery. The 
patients consented to donate the placentae and be tested for 
HCV, HIV1 and 2, and HbsAg. In addition to testing negative for 
these tests, all patients had no evidence of any genital infectious 
diseases, fever (>38°C), premature rupture of the membranes, 
and meconium-stained amniotic fluid.
collection and storage of the human 
amniotic Membranes
The placentae were collected after each elective cesarean delivery 
and were transported in sterile bags on ice to the biomolecular 
lab, where they were bluntly dissected from the chorion under the 
laminar flow hood. They were washed with balanced salt solution 
containing penicillin, streptomycin, neomycin, and amphotericin 
B, placed in tissue culture and glycerol at a ratio of 1:1, and stored 
at −80°C.
Processing of the human amniotic 
Membranes
Human amniotic membrane was processed in two different ways 
for the procedures. For the group receiving the HAM patch, HAM 
was cut into a 2 cm × 2 cm patch, which was then suspended in 
phosphate buffer saline (PBS) and directly sent to the operating 
room in the animal care facility in a sterile bag on ice. For the 
fragmented HAM patch in LR group, a 2 cm × 2 cm HAM patch 
was suspended in PBS, centrifuged, and the resultant fragment 
HAM mixture was put in 2.5 ml of LR, and sent to the operating 
room in the animal care facility in a sterile bag on ice.
surgical Procedures
A total of 168 female BALB/c mice weighing 20–25 g were used 
in this study. The animals were kept in the animal house of the 
American University of Beirut according to the international 
principles of animal care. The mice were ordered in batches of 20 
mice each, in periods ranging from 2 to 3 weeks.
Mice were chosen as the study model due to lack of a 
xenogeneic reaction after HAM transplantation, as seen in the 
Zhang et al. study (20). This study investigated immunological 
and histological reactions in mice after xenotransplantation of 
either fresh HAM or preserved HAM, and compared the results 
FigUre 1 | aspect of a 2 cm × 2 cm haM patch left over the 
cauterized area (group c) prior to closure on the day of surgery.
TaBle 1 | gross adhesion results.
gross adhesion percentage (%) (n)
grade group a group B group c group D
0 0 (0) 7.7 (3) 5.1 (2) 71 (27)
1 and 2 37.5 (15) 53.8 (21) 46.1 (18) 15.7 (6)
3 and 4 62.5 (25) 38.5 (15) 48.8 (19) 13.3 (5)
Total surviving mice 40 39 39 38
Total sampled mice 40 36 37 11
TaBle 2 | adhesion sample pathological grading criteria.
score histological features
inflammation Fibrosis angiogenesis
0 No inflammation No fibrosis No vascular proliferation
1 Scattered infiltrates Patch scattered 
bands
Patchy vascular 
proliferation
2 Continuous infiltrates Dense bands Dense vascular 
proliferation
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between the two groups. The result showed that HAM, fresh or 
preserved, has ideal immunocompatibility and histocompatibil-
ity as a heterologous biomaterial.
All procedures were performed by the same surgeon, 
Mohamad Karim Kechli, experienced in surgery on mice, 
and relevant images were captured using an Olympus SC30 
camera. Abdominal and pelvic areas were shaved 1 day prior 
to the surgical procedure. Cefazolin (400  mg/kg) was given 
30  min prior to the incision for infection prophylaxis. All 
mice received induction of anesthesia using a combination of 
intramuscular ketamine 90–100 mg/kg (Ketalar, Parke-Davis, 
Morris Plains, NJ, USA) and xylazine 10 mg/kg (Gemini, Rugby 
Laboratory, Rockville Center, NY, USA). Mice were draped in 
a sterile fashion and scrubbed using iodine povidone solution. 
A midline incision of 3 cm was then performed. Two experi-
mental injuries, measuring 0.5 cm each, were performed using 
electrocautery at 20 W (Valleylab Generator) applied for 1 s 
on each side of the internal aspect of the abdominal wall.
In the control (Group A), after a midline laparotomy incision 
of 3 cm length, a small cautery lesion of 0.5 mm was done on each 
side of the peritoneum of the abdominal wall, which was then 
closed. Group B underwent the same procedure, but 2.5 ml of LR 
were put in the abdominal cavity prior to closure. In Group C, a 
patch of 2 cm × 2 cm of HAM was left over the cauterized areas 
prior to closure (Figure 1). Group D received the 2 cm × 2 cm 
patch of HAM fragmented and dispersed in a 2.5 ml of LR prior 
to closure. The abdomen was closed using 5-0 nylon interrupted 
sutures, and the wound was covered with Mebo® ointment 
(Julphar Gulf Pharmaceutical, Amman, Jordan).
Pathological analysis
On postoperative day 14, the mice received a fatal dose of furan 
gas, and an autopsy was performed to grossly assess the extent 
of the adhesions. The adhesions were grossly assessed by the 
surgeon according to the modified Nair’s macroscopic adhesion 
classification: grade 0, no adhesions; grade 1, a single adhesive 
band between organs or organs and abdominal wall; grade 2, 
two adhesive bands between organs or organs and abdominal 
wall; grade 3, more than two adhesive bands between organs and 
abdominal wall, or adhesion to intestinal loops without adhesions 
to abdominal wall; and grade 4, thick and complex adhesive band 
between organs or organ and abdominal wall or direct adhesion 
of viscera to abdominal wall. The results are shown in Table 1.
If adhesions were present, an adhesion sample was sent for 
pathology studies. One pathologist (IK), blinded to the group 
of specimen, read all the Hematoxylin & Eosin (H&E)-stained 
histological slides using an Olympus BX40 microscope at a 
magnitude of 100×. The sample slides were fixated in formalin 
and assessed for fibrosis, angiogenesis, and inflammation levels, 
according to the scores shown in Table 2. The inflammation was 
graded as: no inflammation, scattered infiltrates, or continuous 
infiltrates; the fibrosis as: no fibrosis, patchy scattered bands, or 
dense bands; and the angiogenesis as: no vascular proliferation, 
patchy vascular proliferation, and dense vascular proliferation.
Data were entered to the PASW (SPSS version 18.0). A p-value 
<0.05 was considered statistically significant. Statistical analysis 
was done using ANOVA (analysis of variance) for comparing 
multiple variables. For post hoc analysis, two-sample t-test was 
used to determine the difference between the groups.
resUlTs
Mortality
Two mice died in Group A, whereas Groups B, C, and D had 
3, 3, and 4 deaths, respectively. The overall p-value for mortality 
among the groups was 0.87, which shows that there is no signifi-
cant difference among the groups in terms of mortality, Table 3. 
FigUre 3 | aspect of the fragmented amniotic membrane in lactated 
ringer (group D) on autopsy showing a score 1 adhesions.
FigUre 2 | aspect of the amniotic membrane patch (group c) on 
autopsy showing a score 2 adhesions.
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All mice died within 12 h of the procedure and the only plausible 
cause was anesthetic complication. There were no infections, no 
seromas, and no dehiscence.
gross adhesions
For analysis purposes, the adhesion grades assessed using Nair’s 
macroscopic adhesion classification were grouped into three 
categories (0, 1 and 2, 3 and 4). In the control Group A, all mice 
developed gross adhesions, whereas Group D had the highest 
rate of no gross adhesions at 71%. In Group D, 15.7% of mice 
developed grades 1 and 2 adhesions, compared to 37.5% in 
Group A. Groups B and C had almost similar rates of grades 1 
and 2 adhesions. In terms of grades 3 and 4 adhesions, the high-
est percentage of 62.5% was found in Group A and the lowest in 
Group D at 13.3%, Table 1.
The lowest mean for gross adhesions was found to be in Group D 
(1.5 ± 1.0 SD) followed by Groups B (2.0 ± 1.1 SD), C (2.2 ± 1.2 
SD), and A (2.7 ± 1.0 SD). The overall p value of <0.0001 indicated 
a significant difference in gross adhesion formation between the 
groups. Post hoc analysis showed significant decrease in gross 
adhesion formation between the fragmented HAM (Group D) 
and the control Group A. Also, a comparison between Groups C 
and D (Figures 2 and 3) gave a p-value of 0.008 suggesting that 
FigUre 4 | histological slides from fragmented haM in lr mice showing (a) fibrosis, (B,c) inflammation, (D) neoangiogenesis.
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there was a significant decrease in gross adhesion formation in 
Group D as compared to the HAM patch Group C, Table 3.
Pathology results
All mice in the control Group A developed adhesions and were all 
sampled. In total, 92.3, 94.9, and 29% of mice in Groups B, C, and 
D, respectively, developed adhesions and were sampled (Table 1). 
Sampled adhesions were studied for inflammation, fibrosis, and 
angiogenesis. The pathology results of the sampled adhesions, 
when present, are shown in Table 3 (Figure 4).
In terms of inflammation, the least adhesion infiltrates were 
found in Group B, where 47.2% of the mice did not develop infil-
trates, whereas only 18.9% of Group C did not develop infiltrates. 
Group C had the highest rate of scattered and dense infiltrates 
at 48.7 and 32.4%, respectively. The overall p-value for inflam-
mation in the groups was calculated to be 0.11(p-value >0.05); 
therefore, indicating that there is no actual significant difference 
amongst the four groups in terms of inflammation.
Group B had the least fibrosis among the groups where 44.5% 
of mice did not develop fibrosis, 47.2% had patchy scattered 
bands, and 8.3% had dense bands. Similar results were obtained 
for the patchy scattered bands in the four groups (45–55%), with 
the least patchy scattered bands found in the Group D. Groups 
A and B had similar rates of dense bands, 10 and 8.3%, respec-
tively, and Groups C and D had 32.4 and 27.4% of dense bands, 
respectively. The overall p-value of 0.03 indicates that there is a 
significant difference among the groups in terms of fibrosis and 
that Group C has significantly lower fibrosis rates as compared 
to the control (p-value <0.05 =  0.04). Group B had the least 
fibrosis rates; however, the p-value of 0.68 (p-value >0.05) shows 
that there is no significant reduction in fibrosis in Group B as 
compared to the control.
For angiogenesis, overall Group B was associated with the least 
vascular formation in the adhesions. In total, 80.5% of mice in 
Group B did not develop angiogenesis in the adhesions, 13.8% 
had patchy vascular infiltration, and 5.7% had dense vascular 
infiltration. The overall p-value was calculated to be <0.0001 
suggesting a significant difference among the groups in terms of 
angiogenesis. Group B had a p-value of <0.0001 when compared 
to Group A, showing statistical significance, whereas no other 
group had a statistically significant difference compared to the 
control.
DiscUssiOn
In our study, Group D (fragmented HAM in LR) had the least 
rate of gross adhesion formation, where 71% of the mice did not 
develop adhesions. Fibrosis was significantly lowest in Group C as 
compared to the control. Lowest vascular formation in the adhe-
sions was seen in Group B, where 80.5% of mice did not develop 
angiogenesis in adhesions.
The use of dried HAM in adhesion prevention has been tested 
in animal and human applications (21). Patches of HAM have 
been used with the maternal side facing the injury and the patches 
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fixed by cautery or sutures at the lesion site. Controversial results 
were reported by these studies (22). It was reported that the 
anti-adherent properties of HAM are likely to lie in the amniotic 
epithelium or in the properties that derive not only from its stem 
cells but also from its mechanical property as a barrier (21). Petter-
Puchner et al. showed a possibility of remaining pluripotent cell 
activity after cryopreservation (4). LR has been previously shown 
to decrease adhesion formation in rats (23), which prompted us 
to compare it to the other forms of administration of HAM. To 
our knowledge, this comparison was not performed before up 
till now.
In this study, 100% of the Group A (control) developed gross 
adhesions, making it an ideal model for adhesion study. The 
HAM patch was not fixated by stitches or cautery in Group C in 
order to avoid the bias of introducing a confounding factor to the 
adhesion formation. The adhesion formation rate in this group is 
comparable to the Group B (LR group). This can be explained by 
the inability of the non-fixated patch to play its role as a barrier 
as it might have slipped from its application site after ambulation.
In Group D (fragmented HAM in LR), there was a significantly 
lower gross adhesion formation rate compared to the other groups, 
where only 29% of mice developed adhesions compared to 100, 
92.3, and 94.9% of mice in Groups A, B, and C, respectively. This 
might be due to the larger contact surface between the different ele-
ments of HAM and the lesion. We hypothesize that fragmentation 
of HAM releases cells and collagen from HAM, leading to faster 
stimulation of epithelialization than the adhesion fibrin bands. 
Ambulation ensures a better distribution of the HAM’s compo-
nents when suspended in LR as compared to the HAM patch. The 
combination of HAM and LR seems to have a synergistic effect.
Histological testing showed a similar inflammatory response 
in all groups, which was reported to be present even with the use 
of amniotic membranes by Di Loreto et al. (21). This suggests that 
the mechanism of action of all the anti-adhesion agents used in the 
study is independent of the inflammatory reaction. Angiogenesis 
was found to be lowest in the Group B; this can be explained by a 
potential anti-angiogenesis effect of LR solution. The significantly 
lower rate of fibrosis associated with the use of HAM patch can-
not be explained with the current design of the study. The lack 
of a group where fragmented HAM was applied without LR is 
a limitation of the present study as it would have led to a better 
understanding of the fragmented HAM’s properties alone.
The results obtained in this study have a significant relevance 
in human setting as they can help prevent postsurgical abdomino-
pelvic adhesions. Since, caesarian deliveries are associated with 
a high rate of postsurgical adhesions, amniotic membranes 
obtained from a patient undergoing a cesarean surgery can be 
fragmented in LR and placed in her abdomen right after the 
uterine closure and prior to the abdominal closure. This would 
help prevent postoperative abdomino-pelvic adhesions and sub-
sequent complications. Cryopreserved HAM can also be used in 
other gynecological and abdominal surgeries for the same benefit. 
This study opens the field of research about the use of fragmented 
HAM in cesarean deliveries, gynecological and abdominal surger-
ies, in an autologous or homologous fashion.
The use of HAM fragmented in LR is associated with a sig-
nificantly lower incidence of postoperative adhesions in mice 
when compared to LR alone, HAM patch, and control. Further 
studies are needed to understand the mechanism of action of the 
fragmented HAM.
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